Psychedelics As A New Anti‐Inflammatory Therapeutic For Atherosclerosis
The FASEB Journal April 1, 2017 C. Nichols, Melaine N. Sebastian, Thomas W. Flanagan
We previously discovered that serotonin 5‐HT2A receptor activation with psychedelics has potent anti‐inflammatory activity in both cell culture and whole animals, which indicated potent anti‐inflammatory effects in vascular tissues among others. More recently we found that the psychedelic (R)‐DOI potently prevents the development of allergic asthma in a mouse model. The effects of (R)‐DOI were...